Advancements in p95HER2 T Cell Antibody Therapies
Innovative therapies targeting the p95HER2 variant of the HER2 protein are reshaping cancer treatment, especially for resistant tumors. The p95HER2-T cell bispecific antibody demonstrates potential in engaging immune cells while minimizing damage to healthy tissues. Discover the preclinical successes, challenges, and promising future developments of these groundbreaking therapies in oncology. Exploring the Latest Developments in […]
3 minute read